New insights reveal EGFR as a target in KRAS-mutated colon cancer
KRAS mutations are among the most common genetic alterations in cancer and are considered particularly difficult to treat.
KRAS mutations are among the most common genetic alterations in cancer and are considered particularly difficult to treat.